Quantum Genomics Société Anonyme (EPA:ALQGC)

Market Cap	5.02M -0.3%
Revenue (ttm)	10.00 -99.9%
Net Income	-8.89M
EPS	-0.13
Shares Out	69.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,880
Open	0.0734
Previous Close	0.0721
Day's Range	0.0720 - 0.0749
52-Week Range	0.0720 - 0.0749
Beta	-0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 13, 2026

About EPA:ALQGC

Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALQGC

Financial Performance

In 2024, EPA:ALQGC's revenue was 10, a decrease of -99.95% compared to the previous year's 19,796. Losses were -8.89 million, 180.4% more than in 2023.